Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by:…
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.
Official FDA data recordWhat to do
Does your product match this recall?
Scan your barcode or label to compare your product with this notice. We’ll help you check the lot or date code when needed.
Scan BarcodeCheck with your phoneNo account or app download needed. A barcode may need a lot code to confirm a match.
- 1Compare the product, size and lot or date code with this notice.
- 2If your product matches, stop using it and follow the official recall instructions.
- 3Read the official notice for return, refund or disposal instructions.
Recall details
- Firm
- AVEVA Drug Delivery Systems, Inc.
- Status
- Ongoing
- Reported
- Jun 3, 2026
- Started
- May 14, 2026
- Where sold
- Nationwide within the U.S
- Quantity
- 59,808 pouches (4,272 Individual Folding Carton (IFC))
- Notice number
- D-0550-2026
Lots, UPC, dates
Lot #: 56841, Expires: 03/2028
Agency wording
Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.
Source: FDA OTC report. This is not medical advice. Compare your package codes before you act.